Month: May 2024

COMBINED GENERAL MEETING AND BOARD OF DIRECTORS DATED 22 MAY 2024 Press release Paris, 22 May 2024 Combined General Meeting The General Meeting of shareholders of Societe Generale was held on 22 May 2024 at Maison de la Mutualité – 24 rue Saint-Victor – 75005 Paris and was chaired by Mr. Lorenzo Bini Smaghi. Quorum was established at 55.61% (vs 53.45% in 2023):631 shareholders participated by attending the General Meeting in person at the place where it was held on 22 May 2024; 898 shareholders were represented at the General Meeting by a person other than the Chairman; 11 113 shareholders voted online; 2 186 shareholders voted by post; 10 044 shareholders, including 7 650online, representing 1.10% of the share capital, gave proxy to the Chairman; A total of 24 872 shareholders were present or represented and thus participated...

MCLEAN, Va., May 22, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced the pricing of the Freddie Mac Seasoned Loans Structured Transaction Trust (SLST) Series 2024-1, a securitization of approximately $297.5 million including both guaranteed senior and non-guaranteed subordinate securities backed by a pool of seasoned residential mortgage loans. The SLST program is a fundamental part of Freddie Mac’s seasoned loan offerings which reduce less-liquid assets in its mortgage-related investments portfolio and shed credit and market risk via economically reasonable transactions. “This offering marks a first for Freddie Mac’s re-performing loan securitizations,” said Freddie Mac Vice President Kevin Cheng, Head of Mortgage Assets and Risk Transfer. “The debut floating rate certificates in SLST 2024-1 reflect our...

PINE MOUNTAIN, Georgia, May 22, 2024 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), a leading operator of regional safari parks in the United States, today provided Parks! America shareholders detailed instructions outlining the process of converting their paper stock certificates to book entry or electronic recordkeeping format. We believe the benefits of holding any stock, including Parks! America, Inc., in electronic format are compelling. As such, through September 27, 2024, current management of the Company is committed to covering the normal administrative cost charged by its transfer agent, Securities Transfer Corporation (“STC”), for shareholders who elect to make this transition during this offer window. We cannot ensure that this commitment will continue if Focused Compounding...

Charlotte, N.C., May 22, 2024 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (Nasdaq: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has entered into definitive securities purchase agreements for the purchase and sale of an aggregate of 50,000,000 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $0.20 per share of common stock (or common stock equivalent) in a registered direct offering priced at-the-market under Nasdaq rules. The offering is expected to close on or about May 24, 2024 subject to the satisfaction of customary closing conditions. Roth Capital Partners is acting as the exclusive placement agent for the offering. Akoustis...

TORONTO, May 22, 2024 (GLOBE NEWSWIRE) —  Madison Metals Inc. (“Madison” or the “Company”) (CSE: GREN) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that the maiden 2024 drill program has commenced at the Company’s Khan Project at Madison West, located in Namibia’s highly prospective Erongo uranium province.Photo 1: Work underway at Madison’s Khan Uranium Project, Namibia. May 22, 2024.Photo 2: Work underway at Madison’s Khan Uranium Project, Namibia. May 22, 2024.Photo 3: Work underway at Madison’s Khan Uranium Project, Namibia. May 22, 2024. Drilling will focus on the areas outlined as announced in Madison’s news release of April 18, 2024. The Company will publish results as deemed necessary and once fully analyzed. Qualified Person Mary Barton, a Professional Natural Scientist (SACNASP) and a Qualified Person for the...

ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today announced the closing of its previously announced public offering of 8,500,000 shares of its common stock at a public offering price of $0.20 per share. Gross proceeds from the offering are $1.7 million before deducting placement agent fees and offering expenses. Virios Therapeutics intends to use the net proceeds of the offering to commence preparatory activities for its planned IMC-2 Long-COVID Phase 2b study and for general corporate purposes. Maxim Group LLC acted as sole placement agent, on a reasonable best-efforts...

Partnership to expand critical access to EBI’s next-gen secure database Jacksonville, Fla., May 22, 2024 (GLOBE NEWSWIRE) — Everything Blockchain Inc., (OTCMKTS: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage, and protect data, has announced that it’s now part of the Amazon Web Services (AWS) partner program. AWS customers now have access to EBI’s market leading secure database solution, BuildDB. The renowned program not only provides greater access to proven vendor solutions but provides these select vendors with a variety of business enablers as a trusted AWS service provider. EBI’s inclusion in the AWS Partner Program brings significant resources to help achieve company goals, including partner-ready marketing campaigns, POC assistance, access...

SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells. The impact of ABBIE on genome editing cannot be overstated. By providing researchers with a powerful tool for targeted integration of foreign DNA, ABBIE has the potential to revolutionize the...

PRESS RELEASE         22 May 2024 COMBINED GENERAL MEETING OF 22 MAY 2024 ALL THE RESOLUTIONS WERE ADOPTED ADDITIONAL DIVIDEND OF €0.05 PAID ON 27 JUNE 2024 The Combined General Meeting of Bolloré SE was held on 22 May 2024 under the chairmanship of Cyrille Bolloré. All the resolutions presented at the Bolloré SE Combined General Meeting were adopted by between91.72% and 99.99% of the votes cast, representing 94.55% of the total votes. The Ordinary General Meeting in particular approved the payment of a dividend of €0.07 per share, an increase of 17%, representing an additional dividend of €0.05 per share after the interim dividend of €0.02 per share paid in September 2023. This additional dividend is payable solely in cash and will be paid on27 June 2024. Among the resolutions put to the vote at the Combined General Meeting on 22 May...